186 related articles for article (PubMed ID: 16335929)
1. New bradykinin analogues modified in the C-terminal part with sterically restricted 1-aminocyclohexane-1-carboxylic acid.
Labudda-Dawidowska O; Wierzba TH; Prahl A; Kowalczyk W; Gawiński Ł; Plackova M; Slaninová J; Lammek B
J Med Chem; 2005 Dec; 48(25):8055-9. PubMed ID: 16335929
[TBL] [Abstract][Full Text] [Related]
2. New bradykinin analogues substituted in positions 7 and 8 with sterically restricted 1-aminocyclopentane-1-carboxylic acid.
Labudda O; Wierzba T; Sobolewski D; Kowalczyk W; Sleszyńska M; Gawiński L; Plackova M; Slaninová J; Prahl A
J Pept Sci; 2006 Dec; 12(12):775-9. PubMed ID: 17131289
[TBL] [Abstract][Full Text] [Related]
3. New bradykinin B(2) receptor antagonists - influence of C-terminal segment modifications on their pharmacological properties.
Sleszyńska M; Kwiatkowska A; Sobolewski D; Wierzba TH; Katarzyńska J; Zabrocki J; Borovickova L; Slaninová J; Prahl A
Acta Biochim Pol; 2009; 56(4):641-8. PubMed ID: 19997652
[TBL] [Abstract][Full Text] [Related]
4. New bradykinin analogues acylated on the N-terminus: effect on rat uterus and blood pressure.
Labudda O; Wierzba T; Sobolewski D; Sleszyńska M; Gawiński Ł; Plackova M; Slaninová J; Prahl A
Acta Biochim Pol; 2007; 54(1):193-8. PubMed ID: 17220954
[TBL] [Abstract][Full Text] [Related]
5. Novel analogues of bradykinin conformationally restricted in the C-terminal part of the molecule.
Sleszyńska M; Wierzba TH; Malinowski K; Borovičková L; Małuch I; Sobolewski D; Lammek B; Slaninová J; Prahl A
J Pept Sci; 2011 May; 17(5):366-72. PubMed ID: 21412955
[TBL] [Abstract][Full Text] [Related]
6. Modifications in the bradykinin main chain are not necessary for antagonistic activity in rat blood pressure assay.
Prahl A
J Pept Sci; 2007 Mar; 13(3):206-10. PubMed ID: 17183595
[TBL] [Abstract][Full Text] [Related]
7. New acylated bradykinin analogues: effect on rat blood pressure and rat uterus.
Dawidowska O; Prahl A; Wierzba T; Nowakowski L; Kowalczyk W; Slaninová J; Lammek B
J Pept Sci; 2005 Jul; 11(7):436-9. PubMed ID: 15742339
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activities of new side chain and backbone cyclic bradykinin analogues.
Schumann C; Seyfarth L; Greiner G; Paegelow I; Reissmann S
J Pept Res; 2002 Aug; 60(2):128-40. PubMed ID: 12102726
[TBL] [Abstract][Full Text] [Related]
9. New analogues of bradykinin containing a conformationally restricted dipeptide fragment in their molecules.
Derdowska I; Prahl A; Neubert K; Hartrodt B; Kania A; Dobrowolski D; Melhem S; Trzeciak HI; Wierzba T; Lammek B
J Pept Res; 2001 Jan; 57(1):11-8. PubMed ID: 11168884
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of novel peptide agonists of the human bradykinin B2 receptor.
Bélanger S; Bovenzi V; Côté J; Neugebauer W; Amblard M; Martinez J; Lammek B; Savard M; Gobeil F
Peptides; 2009 Apr; 30(4):777-87. PubMed ID: 19111586
[TBL] [Abstract][Full Text] [Related]
11. Highly potent 1-aminocyclohexane-1-carboxylic acid substituted V2 agonists of arginine vasopressin.
Kowalczyk W; Prahl A; Derdowska I; Dawidowska O; Slaninová J; Lammek B
J Med Chem; 2004 Nov; 47(24):6020-4. PubMed ID: 15537356
[TBL] [Abstract][Full Text] [Related]
12. New bradykinin analogs in contraction of rat uterus.
Trzeciak HI; Kozik W; Melhem S; Kania A; Dobrowolski D; Prahl A; Derdowska I; Lammek B
Peptides; 2000 Jun; 21(6):829-34. PubMed ID: 10959005
[TBL] [Abstract][Full Text] [Related]
13. The influence of 1-aminocyclopentane-1-carboxylic acid at position 2 or 3 of AVP and its analogues on their pharmacological properties.
Kowalczyk W; Prahl A; Dawidowska O; Derdowska I; Sobolewski D; Hartrodt B; Neubert K; Slaninová J; Lammek B
J Pept Sci; 2005 Sep; 11(9):584-8. PubMed ID: 15747318
[TBL] [Abstract][Full Text] [Related]
14. Structural modification of the highly potent peptide bradykinin B1 receptor antagonist B9958.
Gera L; Stewart JM; Fortin JP; Morissette G; Marceau F
Int Immunopharmacol; 2008 Feb; 8(2):289-92. PubMed ID: 18182242
[TBL] [Abstract][Full Text] [Related]
15. Bradykinin antagonists modified with dipeptide mimetic beta-turn inducers.
Alcaro MC; Vinci V; D'Ursi AM; Scrima M; Chelli M; Giuliani S; Meini S; Di Giacomo M; Colombo L; Papini AM
Bioorg Med Chem Lett; 2006 May; 16(9):2387-90. PubMed ID: 16504505
[TBL] [Abstract][Full Text] [Related]
16. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 4. Discovery of novel frameworks mimicking the active conformation.
Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Inamura N; Asano M; Aramori I; Hatori C; Sawai H; Oku T; Tanaka H
J Med Chem; 1998 Nov; 41(23):4587-98. PubMed ID: 9804698
[TBL] [Abstract][Full Text] [Related]
17. Analogues of a potent oxytocin antagonist with truncated C-terminus or shorter amino acid side chain of the basic amino acid at position 8.
Flouret G; Chaloin O; Slaninová J
J Pept Sci; 2003 Jun; 9(6):393-401. PubMed ID: 12846485
[TBL] [Abstract][Full Text] [Related]
18. A proton magnetic resonance study of two synthetic agonist-antagonist pairs of bradykinin analogues.
Otter A; Bigler P; Stewart JM; Kotovych G
Biopolymers; 1993 May; 33(5):769-80. PubMed ID: 8393713
[TBL] [Abstract][Full Text] [Related]
19. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
Bellucci F; Meini S; Cucchi P; Catalani C; Giuliani S; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
Eur J Pharmacol; 2004 May; 491(2-3):121-5. PubMed ID: 15140628
[TBL] [Abstract][Full Text] [Related]
20. MEN16132, a novel potent and selective nonpeptide kinin B2 receptor antagonist: in vivo activity on bradykinin-induced bronchoconstriction and nasal mucosa microvascular leakage in anesthetized guinea pigs.
Valenti C; Cialdai C; Giuliani S; Lecci A; Tramontana M; Meini S; Quartara L; Maggi CA
J Pharmacol Exp Ther; 2005 Nov; 315(2):616-23. PubMed ID: 16027229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
